Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
BridgeBio Pharma Q3 Net Loss Narrows, Revenue Rises

BridgeBio Pharma Q3 Net Loss Narrows, Revenue Rises

MT newswireMT newswire2026/10/29 20:55
04:55 PM EDT, 10/29/2026 (MT Newswires) -- BridgeBio Pharma (BBIO) reported a Q3 net loss late Thursday of $0.42 per diluted share, narrowing from a loss of $0.95 a year earlier. Analysts polled by FactSet expected a loss of $0.54. Revenue for the quarter ended Sept. 30 rose to $353.2 million, from $120.7 million a year earlier. Analysts expected $293.5 million.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!